HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liqing Du Selected Research

Poly(ADP-ribose) Polymerase Inhibitors

12/2021BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liqing Du Research Topics

Disease

26Neoplasms (Cancer)
03/2024 - 03/2013
7Lung Neoplasms (Lung Cancer)
01/2024 - 06/2016
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 03/2013
4Inflammation (Inflammations)
04/2023 - 07/2013
3Genomic Instability
11/2023 - 01/2019
3Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 09/2018
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
04/2024 - 07/2023
2Fibrosis (Cirrhosis)
03/2024 - 09/2023
2Hyperlipidemias (Hyperlipidemia)
04/2023 - 01/2023
2Breast Neoplasms (Breast Cancer)
09/2021 - 10/2018
2Enteritis
03/2021 - 10/2018
2Radiation Injuries (Radiation Sickness)
09/2014 - 07/2013
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
03/2024
1Disease Progression
01/2024
1Bloom Syndrome
11/2023
1Diarrhea
07/2023
1Obesity
04/2023
1Non-alcoholic Fatty Liver Disease
04/2023
1Overnutrition
04/2023
1Neoplasm Metastasis (Metastasis)
04/2023
1Pelvic Neoplasms
11/2022
1Triple Negative Breast Neoplasms
10/2022
1Atherosclerosis
09/2021
1Weight Loss (Weight Reduction)
08/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2020
1Hypersensitivity (Allergy)
01/2020
1Atrophy
01/2018
1Nervous System Diseases (Neurological Disorders)
01/2018
1Multiple Myeloma
01/2018
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Carcinogenesis
01/2018
1Wounds and Injuries (Trauma)
01/2017
1Colonic Neoplasms (Colon Cancer)
01/2014

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
11/2023 - 07/2013
5ResveratrolIBA
04/2020 - 07/2013
4DNA (Deoxyribonucleic Acid)IBA
11/2023 - 12/2018
4Sirtuin 1IBA
04/2020 - 07/2013
4CaspasesIBA
12/2018 - 03/2013
3Bile Acids and Salts (Bile Acids)IBA
04/2024 - 04/2023
3Reactive Oxygen Species (Oxygen Radicals)IBA
11/2022 - 01/2017
3AGuIXIBA
10/2022 - 12/2020
2Immune Checkpoint InhibitorsIBA
01/2024 - 08/2022
2GadoliniumIBA
10/2022 - 12/2020
2Therapeutic UsesIBA
08/2022 - 12/2018
2Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2020
2Bloom syndrome proteinIBA
12/2021 - 01/2019
2Peptides (Polypeptides)IBA
09/2021 - 05/2016
2thymoquinoneIBA
03/2021 - 10/2018
2InflammasomesIBA
04/2020 - 07/2013
2brusatolIBA
01/2020 - 06/2016
2NAD (NADH)IBA
01/2018 - 07/2013
2CytokinesIBA
01/2018 - 07/2013
1choloylglycine hydrolaseIBA
04/2024
1InulinFDA Link
03/2024
1CollagenIBA
03/2024
1Glutathione (Reduced Glutathione)IBA
01/2024
13- propylidene- delta(1)- pyrroline- 5- carboxylic acidIBA
01/2024
1AntioxidantsIBA
01/2024
1obeticholic acidIBA
04/2023
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2023
1Sterol Regulatory Element Binding Protein 1IBA
01/2023
1ElementsIBA
10/2022
1MetalsIBA
10/2022
1Programmed Cell Death 1 ReceptorIBA
08/2022
1Metformin (Glucophage)FDA LinkGeneric
01/2022
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2022
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
12/2021
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
12/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021
1olaparibIBA
12/2021
1ML216IBA
12/2021
1CarbonIBA
09/2021
1Radiation-Sensitizing AgentsIBA
09/2021
1Amino AcidsFDA Link
09/2021
1EnzymesIBA
08/2021
1shellacIBA
08/2021
1Inhibitor of Apoptosis ProteinsIBA
05/2021
1trioctyl phosphine oxide (TOPO)IBA
01/2021
1InterleukinsIBA
04/2020
1MelatoninIBA
12/2018
1Conditioned Culture MediaIBA
10/2018
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2018
1Sirtuin 3IBA
09/2018
1Actins (F Actin)IBA
01/2018
1Circular RNAIBA
01/2018
1carfilzomibIBA
01/2018
1Proteasome InhibitorsIBA
01/2018
1Fluorescein-5-isothiocyanate (FITC)IBA
05/2016
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
09/2014
1Small Interfering RNA (siRNA)IBA
01/2014
1RNA (Ribonucleic Acid)IBA
03/2013
1Mitochondrial Proteins (Mitochondrial Protein)IBA
03/2013
1Caspase 3 (Caspase-3)IBA
03/2013

Therapy/Procedure

25Radiotherapy
03/2024 - 03/2013
11Therapeutics
03/2024 - 03/2013
2Immunotherapy
01/2024 - 08/2022
1Transplantation
03/2024
1Immunomodulation
08/2022
1Chemoradiotherapy
01/2018